Management of Antithrombotic Therapy after Acute Coronary Syndromes
- PMID: 33534976
- PMCID: PMC9275395
- DOI: 10.1056/NEJMra1607714
Management of Antithrombotic Therapy after Acute Coronary Syndromes
Figures

Comment in
-
Antithrombotic Therapy after Acute Coronary Syndromes.N Engl J Med. 2021 May 13;384(19):1872-1873. doi: 10.1056/NEJMc2103789. N Engl J Med. 2021. PMID: 33979502 No abstract available.
-
Antithrombotic Therapy after Acute Coronary Syndromes.N Engl J Med. 2021 May 13;384(19):1873. doi: 10.1056/NEJMc2103789. N Engl J Med. 2021. PMID: 33979503 No abstract available.
References
-
- Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326(4):242–250. - PubMed
-
- Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–e596. - PubMed
-
- Tahhan AS, Vaduganathan M, Greene SJ, et al. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. JAMA Cardiol. 2020. - PubMed
-
- Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical